| 411 |
Oxidative Modification of Low-Density Lipoprotein in Relation to Dyslipidemia and Oxidant Status in Children with Steroid Sensitive Nephrotic Syndrome. |
2008 |
| 412 |
The effectiveness of retinoic acid treatment in bladder cancer: Impact on recurrence, survival and TGFα and VEGF as end-point biomarkers. |
2008 |
| 413 |
Using A Minigene Assay to Assess The Function of A Polymorphism Associated with Intra-uterine Growth Restriction. |
2008 |
| 414 |
A novel therapeutic drug (copper nicotinic acid complex) for non-alcoholic fatty liver |
2007 |
| 415 |
A novel therapeutic drug (copper nicotinic acid complex) for non‐alcoholic fatty liver |
2007 |
| 416 |
Antiphospholipid Antibodies and Vascular endothelial growth Factor in Systemic Lupus Erythmatosus, Rheumatoid Arthritis and Systemic Sclerosis |
2007 |
| 417 |
Association between the Levels of B- type Natriuretic Peptide,
and C-reactive protein in Patients with Chronic Renal Failure |
2007 |
| 418 |
Association between the Levels of B- type Natriuretic Peptide,
and C-reactive protein in Patients with Chronic Renal Failure |
2007 |
| 419 |
Association between the Levels of B-type Natriuretic Peptide, and C-reactive protein in Patients with Chronic Renal Failure |
2007 |
| 420 |
Association between the Levels of B-type Natriuretic Peptide, and C-reactive protein in Patients with Chronic Renal Failure |
2007 |
هل لديك سؤال ؟
